SCHEMBL202758

SCHEMBL202758

O=C(O)CCCCCCCS

nearest known ligand 0.94

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 2/20 0.94
TSHR P16473 5/20 0.71
LMNA P02545 3/20 0.71
NFKB1 P19838 1/20 0.71
PMP22 Q01453 1/20 0.71
GPR84 Q9NQS5 7/20 0.57
FFAR1 O14842 2/20 0.57
FFAR4 Q5NUL3 2/20 0.57
SLC22A6 Q4U2R8 2/20 0.56
PPARG P37231 6/20 0.55
PPARD Q03181 6/20 0.55
PPARA Q07869 6/20 0.55
HDAC11 Q96DB2 5/20 0.55
ALDH1A1 P00352 3/20 0.55
TLR2 O60603 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
MEN1 O00255 2/20 0.55
FABP4 P15090 2/20 0.55
ALOX15 P16050 2/20 0.55
PTPN1 P18031 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2837455 1.00 FOLH1 (0.94) FOLH1TSHRLMNANFKB1PMP22
SCHEMBL4528519 1.00 FOLH1 (0.94) FOLH1TSHRLMNANFKB1PMP22
SCHEMBL4521988 1.00 FOLH1 (0.94) FOLH1TSHRLMNANFKB1PMP22
SCHEMBL4538714 1.00 FOLH1 (0.94) FOLH1TSHRLMNANFKB1PMP22
SCHEMBL4531504 1.00 FOLH1 (0.94) FOLH1TSHRLMNANFKB1PMP22
SCHEMBL4533686 1.00 FOLH1 (0.94) FOLH1TSHRLMNANFKB1PMP22
SCHEMBL4533669 1.00 FOLH1 (0.94) FOLH1TSHRLMNANFKB1PMP22
SCHEMBL173209 1.00
SCHEMBL4536912 1.00 FOLH1 (0.94) FOLH1TSHRLMNANFKB1PMP22
SCHEMBL1954234 1.00 FOLH1 (0.94) FOLH1TSHRLMNANFKB1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078270-A1 THREE-DIMENSIONAL SURFACE PATTERNING NAT RES COUNCIL CANADA (CA) 2026-03-19 US claimed
US-20250361441-A1 ETCHING COMPOSITION, ETCHING METHOD, METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE, AND METHOD FOR MANUFACTURING GATE-ALL-AROUND-TYPE TRANSISTOR MITSUBISHI CHEMICAL CORPORATION (JP) 2025-11-27 US claimed
EP-4649308-A2 APTAMER-BASED ANALYTE MONITORING SYSTEM Biolinq, Inc. (US) 2025-11-19 EP claimed
EP-4590490-A1 THREE-DIMENSIONAL SURFACE PATTERNING National Research Council of Canada (CA) 2025-07-30 EP claimed
WO-2025023638-A1 METHOD FOR PRODUCING AMMONIA USING QUANTUM DOT-BACTERIA HYBRID SYSTEM 한국과학기술원 2025-01-30 WO claimed
CN-116444177-B Method for enhancing interface connection strength of inorganic material and polymer 吉林大学 2025-01-24 CN claimed
WO-2025005206-A1 ETCHING LIQUID, ETCHING METHOD, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE 三菱ケミカル株式会社 2025-01-02 WO claimed
CN-119060572-A Water-based inorganic zinc-rich primer with good stability and easiness in construction and preparation method thereof 江苏苏博特新材料股份有限公司 2024-12-03 CN claimed
CN-119015131-A Multifunctional hard tissue treating agent based on sulfhydryl and carboxylic acid group structural compound and application thereof 浙江大学 2024-11-26 CN claimed
CN-118671035-A Surface plasma resonance sensor and preparation method and application thereof 中国科学院大学 2024-09-20 CN claimed
US-20130123456-A1 Method for Functionalizing Natural Fatty Substances Centre National De La Recherche Scienitique (C.N.R.S.) (FR) 2013-05-16 US claimed
EP-2536406-A2 BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES Microbion Corporation (US) 2012-12-26 EP claimed
WO-2012021754-A2 BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES MICROBION CORPORATION (US) 2012-02-16 WO claimed
US-20110207232-A1 WATER SOLUBLE PH RESPONSIVE FLUORESCENT NANOPARTICLES UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2011-08-25 US claimed
WO-2011097347-A2 BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES MICROBION CORPORATION (US) 2011-08-11 WO claimed
WO-2011041772-A2 MEMORY DEVICES, METHODS OF STORING AND READING DATA, SMM JUNCTIONS, AND METHODS OF PREPARING ALUMINA SUBSTRATES THE UNIVERSITY OF MEMPHIS RESEARCH FOUNDATION (US) 2011-04-07 WO claimed
US-7846731-B2 Method of introducing nucelic acid KYOTO UNIVERSITY (JP) 2010-12-07 US claimed
EP-1672063-B1 METHOD OF INTRODUCING NUCLEIC ACID UNIV KYOTO (JP) 2009-10-14 EP claimed
US-20070059832-A1 Method of introducing nucelic acid KYOTO UNIVERSITY (JP) 2007-03-15 US claimed
EP-1672063-A1 METHOD OF INTRODUCING NUCLEIC ACID Kyoto University (JP) 2006-06-21 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078270-A1 THREE-DIMENSIONAL SURFACE PATTERNING ITGB3, VCL, ITGAM FOLH1 1948/4885TSHR 3455/4885LMNA 1728/4885
US-20130123456-A1 Method for Functionalizing Natural Fatty Substances FASN, ALOX5, FFAR3 FOLH1 926/4885TSHR 2604/4885LMNA 1842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.